Ophthalmology

Our Ophthalmology research is primarily focused on age-related macular degeneration (AMD). Our approach is to better understand the role of the complement system in the onset and progression of the disease with the ultimate goal of correcting the aberrant complement cascade to prevent the disease (through the inhibition of the complement system). We also develop compounds for topical delivery to treat retinal disease, including AMD.

Our Ophthalmology research concentrates on the treatment and prevention of age-related macular degeneration and the treatment of glaucoma.